In silico pharmacology: drug design and discovery’s gate to the future
|Country:||United States of America|
Introduction of new drugs and novel therapeutic solutions is a long and costly process (Myers and Baker2001; DiMasi et al.,2003). Traditionally, pharmacologists strive to optimize and accelerate this process by developing new in vivo and in vitro investigation strategies. However, the last decades have been witnessing the rise of alternative research models, the so-called in silico approaches, using computational environments as their experimental laboratories. [...] Despite the increasing interest in this field of research, publication platforms with dedicated agenda to in silico pharmacology are missing. With the launch of our journal, we aim to fill this gap and provide a forum for interdisciplinary research articles that specifically address computational approaches in drug-design and multi-scale analysis of bioactive substances from the cellular up to behavioral level.
|Audience:||Scientists - Researchers - Industry|
|User access:||Open access|
|Relevance:||Replacement - Reduction|
|Purpose:||Documentation and information|
|Legislative framework:||Medicines legislation|
|Technology/Tools:||Non-testing methods (in silico)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.